Socio-demographic and disease related characteristics associated with unplanned emergency department visits by cancer patients: a retrospective cohort study.
Cohort Studies
Demography
Emergency Service, Hospital
/ statistics & numerical data
Female
Hospitals, Public
/ statistics & numerical data
Humans
Male
Middle Aged
Neoplasms
/ therapy
Patient Discharge
/ statistics & numerical data
Residence Characteristics
/ statistics & numerical data
Retrospective Studies
Socioeconomic Factors
Victoria
Andersen’s behavioral model of health service utilization
Antineoplastics
Cancer
Chemotherapy
Emergency department
Oncology
Risk reduction
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
06 Sep 2019
06 Sep 2019
Historique:
received:
26
01
2019
accepted:
03
09
2019
entrez:
8
9
2019
pubmed:
8
9
2019
medline:
24
12
2019
Statut:
epublish
Résumé
Emergency department (ED) presentations made by patients having cancer treatment are associated with worth outcomes. This study aimed to explore the socio-demographic and disease related characteristics associated with ED presentation, frequent ED presentations, and place of discharge for cancer patients receiving systemic cancer therapies in the ambulatory setting. This was a single site, retrospective observational cohort design. Hospital data for patients treated in the Day Oncology Unit of a large public tertiary hospital in Melbourne, Australia between December 2014 and November 2017 were extracted from clinical databases and retrospectively matched to ED attendance records. Andersen's Behavioral Model of Health Service Utilisation provided the conceptual framework for exploring associations between socio-demographic and disease characteristics and ED use. A total of 2638 individuals were treated in the Day Oncology Unit over the study dates. Of these, 1182 (45%) made an unplanned ED presentation within 28 days of receiving systemic cancer therapy. One hundred and twenty-two (12%) patients attended the ED on two or more occasions within 28 days; while 112 (10%) patients attended the ED four or more times (within 28 days of receiving systemic cancer therapy) within any given 12 month period. Being born outside of Australia was independently related to making an unplanned ED presentation within 28 days of receiving anti-cancer therapy (p < .01) as was being diagnosed with head and neck (p = .03), upper gastrointestinal (p < .001), colorectal (p < .001), lung (p < .001), skin (p < .001) or breast cancer (p = .01). This study identified a subgroup of cancer patients for whom an ED presentation is more likely. Better understanding of socio-demographic and disease related characteristics associated with the risk of an ED presentation may help inform targeted follow up of patients, to mitigate potentially avoidable ED presentation and optimize outcomes of care.
Sections du résumé
BACKGROUND
BACKGROUND
Emergency department (ED) presentations made by patients having cancer treatment are associated with worth outcomes. This study aimed to explore the socio-demographic and disease related characteristics associated with ED presentation, frequent ED presentations, and place of discharge for cancer patients receiving systemic cancer therapies in the ambulatory setting.
METHODS
METHODS
This was a single site, retrospective observational cohort design. Hospital data for patients treated in the Day Oncology Unit of a large public tertiary hospital in Melbourne, Australia between December 2014 and November 2017 were extracted from clinical databases and retrospectively matched to ED attendance records. Andersen's Behavioral Model of Health Service Utilisation provided the conceptual framework for exploring associations between socio-demographic and disease characteristics and ED use.
RESULTS
RESULTS
A total of 2638 individuals were treated in the Day Oncology Unit over the study dates. Of these, 1182 (45%) made an unplanned ED presentation within 28 days of receiving systemic cancer therapy. One hundred and twenty-two (12%) patients attended the ED on two or more occasions within 28 days; while 112 (10%) patients attended the ED four or more times (within 28 days of receiving systemic cancer therapy) within any given 12 month period. Being born outside of Australia was independently related to making an unplanned ED presentation within 28 days of receiving anti-cancer therapy (p < .01) as was being diagnosed with head and neck (p = .03), upper gastrointestinal (p < .001), colorectal (p < .001), lung (p < .001), skin (p < .001) or breast cancer (p = .01).
CONCLUSIONS
CONCLUSIONS
This study identified a subgroup of cancer patients for whom an ED presentation is more likely. Better understanding of socio-demographic and disease related characteristics associated with the risk of an ED presentation may help inform targeted follow up of patients, to mitigate potentially avoidable ED presentation and optimize outcomes of care.
Identifiants
pubmed: 31492185
doi: 10.1186/s12913-019-4509-z
pii: 10.1186/s12913-019-4509-z
pmc: PMC6731557
doi:
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
647Références
Support Care Cancer. 2011 Jul;19(7):963-9
pubmed: 20499108
Cancer Nurs. 2011 May-Jun;34(3):E27-32
pubmed: 21512342
Eur J Cancer. 2012 Dec;48(18):3328-34
pubmed: 22683169
Support Care Cancer. 2013 Feb;21(2):397-404
pubmed: 22722887
Psychosoc Med. 2012;9:Doc11
pubmed: 23133505
Ann Emerg Med. 2013 Apr;61(4):427-437.e5
pubmed: 23290526
J Oncol Pract. 2014 Jan;10(1):63-7
pubmed: 24443735
Support Care Cancer. 2014 Jul;22(7):1875-81
pubmed: 24557010
Mol Clin Oncol. 2014 Mar;2(2):322-326
pubmed: 24649355
J Pain Symptom Manage. 2015 Mar;49(3):497-504
pubmed: 25131891
Emerg Med Australas. 2015 Aug;27(4):336-42
pubmed: 26095210
Int Emerg Nurs. 2016 Jan;24:35-8
pubmed: 26120049
Support Care Cancer. 2016 Mar;24(3):1251-60
pubmed: 26306522
Support Care Cancer. 2016 Jun;24(6):2549-56
pubmed: 26694719
J Oncol Pract. 2016 Feb;12(2):151-2; e138-48
pubmed: 26869655
Oncologist. 2016 Mar;21(3):301-7
pubmed: 26921289
Cancer Nurs. 2017 Mar/Apr;40(2):135-144
pubmed: 26925998
Ann Emerg Med. 2016 Aug;68(2):213-21
pubmed: 27033142
J Oncol Pract. 2016 May;12(5):e594-602
pubmed: 27048613
Worldviews Evid Based Nurs. 2016 Dec;13(6):420-431
pubmed: 27243574
Support Care Cancer. 2017 Jan;25(1):209-212
pubmed: 27614868
Support Care Cancer. 2017 May;25(5):1409-1415
pubmed: 27966026
Support Care Cancer. 2017 Aug;25(8):2377-2385
pubmed: 28275897
Palliat Med. 2018 Feb;32(2):426-438
pubmed: 28631517
J Clin Oncol. 2017 Nov 1;35(31):3610-3617
pubmed: 28850290
JAMA Oncol. 2017 Oct 12;3(10):e172450
pubmed: 28859189
Palliat Med. 2018 Feb;32(2):439-446
pubmed: 29130378
J Oncol Pract. 2018 May;14(5):306-313
pubmed: 29664697
Intern Med J. 2018 May;48(5):583-587
pubmed: 29722200
Cancer Med. 2018 Sep;7(9):4434-4446
pubmed: 30117313
Eur J Cancer Care (Engl). 2019 Jan;28(1):e12909
pubmed: 30238542